BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
138 hedge funds and large institutions have $32.7M invested in bluebird bio in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-10
Holders Change %
-6.76%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
38
Reduced
44
Closed
26
Calls
$295K
Puts
$492K
Net Calls
-$197K
Net Calls Change
+$298K
Top Buyers
| 1 |
APM
1
Avidity Partners Management
Dallas,
Texas
|
$847K |
| 2 |
ECM
2
ExodusPoint Capital Management
New York
|
$674K |
| 3 |
LPC
3
Lion Point Capital
New York
|
$820K |
| 4 |
4
Morgan Stanley
New York
|
$503K |
| 5 |
5
Goldman Sachs
New York
|
$418K |
